Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 162 results found. Search for [ Pankaj Patel ]

Results 1 to 21 of 162
BusinessToday.In
May 12, 2021
The consortium, including Canada Pension Plan Investment Board and Rakesh Jhunjhunwala-backed RARE Enterprises, has agreed to purchase the Undertaking through an SPV controlled by them, in the name of Zenex Animal Health India Private Limited for Rs 2,921 crore


BusinessToday.In
April 19, 2021
After a heated argument, the couple was taken to the Daryaganj police station and a case was filed against them under various sections


BusinessToday.In
January 4, 2021
The phase-2 trials of Zydus Cadila's coronavirus vaccine had been conducted in around 1,000 healthy adults


BusinessToday.In
December 13, 2020
VK Paul says globally, 33 vaccines are in clinical trial phase, of which 10 vaccines are in advanced trial phase. Key consideration while prioritising population for vaccine inoculation is accessing people with risk to mortality and protection of healthcare system and response system


PB Jayakumar
December 9, 2020
The drug aims to control Alkaline Phosphotase (ALP) or bilirubin, reduces strong side effects of existing drugs such as pruritus or increase in LDL-cholesterol and brings in better tolerance and efficacy


BusinessToday.In
November 28, 2020
PM Modi took stock of the work being done so far on the development of coronavirus vaccine at the Zydus Cadila research centre


BusinessToday.In
November 27, 2020
The company could be looking at manufacturing 100 million doses to begin with, as per Chairman Pankaj Patel.


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


PB Jayakumar & Joe C Mathew
October 26, 2020
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020


PTI
September 22, 2020
A vaccine is definitely needed to control the spread of this disease, but the vaccine alone is not enough, and other efforts such as social distancing, wearing mask, isolating and testing people will continue to remain important


BusinessToday.In
August 7, 2020
Coronavirus vaccine news update: Serum Institute of India would have exclusive rights for the supply of the Novavax COVID-19 vaccine in India


PB Jayakumar
August 5, 2020
The vaccine, using the platform of plasmid DNA, was found to be safe and well tolerated in the Phase I, which began on 15 July, said Zydus Cadila


BusinessToday.In
August 5, 2020
Coronavirus vaccine news update: The Phase II trial will evaluate the humoral and cellular immune response for the coronavirus vaccine candidate, keeping in line with the current global protocols


Joe C Mathew
August 3, 2020
Indian vaccine manufacturers are waiting for a vaccination plan from the government so that they can set aside stocks of vaccines when they are approved for production


BusinessToday.In
July 18, 2020
Coronavirus vaccine news update: Goldman Sachs believes that a coronavirus vaccine could be approved by the end of the year. It predicts Moderna and Pfizer's candidates to be the first ones to pass regulatory hurdles


BusinessToday.In
July 17, 2020
Coronavirus vaccine news update: Zydus Cadila Chairman Pankaj Patel has said that he expects a potential COVID vaccine to be out in the market by early next year


PTI
July 17, 2020
\"We are looking at about seven or a little more than seven months for the vaccine, provided the data is encouraging and the vaccine is proven to be effective during the trials,\" Chairman Pankaj Patel told Reuters in an interview


PTI
July 16, 2020
ZyCoV-D and COVAXIN, developed by city-based Bharat Biotech in collaboration with Indian Council of Medical Research, are the only two vaccine candidates to have got a nod from the drug regulatory body to conduct human trials


PAGES 1 OF 9  12345